Robin Riley
Phase 1 clinical trials have been approved for a nasal COVID-19 vaccine that blocks transmission, a novel approach that could be useful for a variety of respiratory infections for which we have vaccines.
Shout out to Washington University in St. Louis for their work on this!
GNU social JP is a social network, courtesy of GNU social JP管理人. It runs on GNU social, version 2.0.2-dev, available under the GNU Affero General Public License.
All GNU social JP content and data are available under the Creative Commons Attribution 3.0 license.